Tag: COVID-19
-
Faculty Weigh in on the COVID-19 Response
There are variety of ways improve care delivery, interpret new information, and maintain clinical trials and experiments in the face of the COVID-19 pandemic, according to recent editorials published by Feinberg faculty.
-
Adapting the Education Centered Medical Home to the COVID-19 Crisis
Students are conducting telehealth visits and reaching out to patients at high risk of complications from COVID-19, part of the transition of the Education Centered Medical Home to virtual care.
-
Sustaining Community Research Partnerships During COVID-19
The Center for Community Health’s Alliance for Research in Chicagoland Communities (ARCC) hosted a virtual discussion for participants to share experiences, strategies and challenges about engaging and supporting community-engaged research partners during the COVID-19 pandemic.
-
Older Adults Didn’t Think COVID-19 Would Affect Them
Many individuals in the highest risk category for COVID-19 because of multiple chronic health conditions didn’t think the disease would affect them and reported not changing their behavior at the beginning of Chicago’s outbreak, according to a new study.
-
Heart Disease, Racial Disparities and COVID-19
Northwestern Medicine cardiovascular experts discuss how racial disparities, including lower socioeconomic status and pre-existing cardiovascular conditions, can lead African-Americans to be at higher risk for contracting and dying from COVID-19.
-
First-Year Student Helps Organize COVID-19 Student Volunteer Effort
First-year medical student Tazim Merchant co-organized the “Students Supporting the Community During COVID-19” project, a volunteer effort among medical students and graduate students at Feinberg that support healthcare workers, older community members and working parents in Chicago during the COVID-19 pandemic.
-
COVID-19 Drug Trial Launches at Northwestern Medicine
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.
-
Northwestern Scientists Transform Lab for COVID-19 Testing
A special COVID-19 testing team has been put in place at Northwestern, with the goal of at least quadrupling the number of tests processed at Northwestern Medicine hospitals — from about 90 per day to more than 350 per day — and in the process, greatly reducing test result turnaround times.
-
Soulakis Joins IDPH to Fight COVID-19
Nicholas Soulakis, PhD, is taking a leave of absence from the medical school to work as an epidemiologist in the Illinois Department of Public Health Office of Policy, Planning and Statistics.
-
Seeking Answers: Clinician-Scientists Respond to COVID-19
Gary Noskin, MD, professor of Medicine in the Division of Infectious Diseases and chief medical officer at Northwestern Memorial Hospital, answers questions about how Northwestern’s clinical research team is responding to the COVID-19 pandemic.
